JOHN VIERLING to Triazoles
This is a "connection" page, showing publications JOHN VIERLING has written about Triazoles.
Connection Strength
0.126
-
Seladelpar (MBX-8025), a selective PPAR-d agonist, in patients with primary biliary cholangitis with an inadequate response to ursodeoxycholic acid: a double-blind, randomised, placebo-controlled, phase 2, proof-of-concept study. Lancet Gastroenterol Hepatol. 2017 10; 2(10):716-726.
Score: 0.126